Dental manufacturer Septodont recently announced that effective June 2, 2025, Karim Khadr will be appointed chief executive officer (CEO).
The world leader in dental anesthesia and leading manufacturer of dental pharmaceuticals and medical devices is making a change in its governance structure. Khadr will succeed Olivier Schiller who will continue to serve the company as chairman of the board.
“This development is a natural next step for our group and a decision I have made as I approach my 65th birthday”, said Schiller in a press release. “I have worked side by side with Karim since he joined Septodont in 2021 and have experienced first-hand his strategic mindset, his values and commitment to our employees and our customers. He is a highly accomplished leader, and it is with great confidence that I am handing over my responsibilities as chief executive officer.”
Khadr is a senior executive with over 30 years of experience, serving in various sales, marketing, business development and product management functions, in both large and small organizations in the medical devices and diagnostics industry. He joined Septodont four years ago as global dental president in charge of sales, marketing and innovation.
“I am privileged to have been given the opportunity to continue building on the success that Septodont has achieved under Olivier’s exceptional leadership, and I am excited to take on this responsibility starting in June. I look forward to working closely with the management team and all our employees to continue successfully executing on our strategy going forward”, added Khadr.
As Olivier moves into his new seat as chairman of the board, he will continue to serve the organization focusing on the company’s long-term growth and providing strategic direction to the board.
Since its inception in 1932, Septodont develops, produces and distributes a large range of products and solutions dedicated to serving the needs of dental professionals across the world.
The company offers a variety of products for endodontics, pain management, periodontics, and more. BioRoot Flow bioceramic root canal sealer and BufferPro 8.4% sodium bicarbonate buffer solution are just two of many popular products developed by Septodont.
Source: www.septodontcorp.com
News 23 January 2025
Septodont, the dominant global leader in dental anesthetics, has made a strategic investment in Balanced Pharma Inc. (“BPI”) as part of an institutional funding round, and Septodont COO Atif Zia...
Products 22 October 2024
Septodont and Premier Dental Announce Partnership to Revolutionize Pain Management With BufferPro
Septodont Inc., a global leader in dental anesthetic products, and Premier Dental, a renowned provider of innovative dental solutions, are pleased to announce a strategic distribution agreement aimed...
News 17 February 2026
PDS Health, a leading integrated healthcare support organization, has selected Pearl as its enterprise partner to expand the use of artificial intelligence that supports real-time radiologic review...
News 04 February 2026
Coast Dental, a patient-centric dental organization with 88 locations across the United States, has selected Denticon by Planet DDS to support operational consistency, interoperability, and...
Products 05 January 2026
Heartland Dental, the nation’s leading dental support organization, today announced that it has selected Dentira as the enterprise lab management platform for supported practices.
Dentistry Today recently attended a robotic-assisted dental implant procedure performed by Jay Neugarten, DDS, MD, FACS, utilizing the Yomi S robotic guidance s
Endodontics 21 April 2026
For a daily dental practice, the Panoramic (PANO) X-ray film is one of the most commonly used dental X-rays.
Editorials 21 April 2026
NYU Dentistry Receives $5M to Expand Oral Health Care for Children with Disabilities
State funding will create dedicated space for pediatric and adolescent care and improve access for people with disabilities across the lifespan